1. Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia 
Ling Ge, Fan Ye, Xinliang Mao, Jia Chen, Aining Sun, Xiaming Zhu, Huiying Qiu, Zhengming Jin, Miao Miao, Chengcheng Fu, Xiao Ma, Feng Chen, Shengli Xue, Changgeng Ruan, Depei Wu, Xiaowen Tang 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 7, Pages (July 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Cumulative incidence of EMR after allo-HSCT for AL. EMR with or without BMR (dotted line), 7.9% (n = 26); isolated EMR (solid line), 3.1% (n = 11); EMR with concurrent BMR (dashed line), 4.7% (n = 15). (B) Cumulative incidence of EMR after HSCT for AML versus ALL (4.6% versus 12.9%; P = .009).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Estimated 3-year OS for patients with AL relapse post-HSCT. Isolated EMR (solid line), 18.2%; isolated BMR (dashed line), 12.0%; EMR with concurrent BMR (dotted line), 8.0%; P = .206.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions